441780-11-6

Basic information

• Product Name: 1(2H)-PyriMidineacetic acid, 4-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-2-oxo-
• Synonyms: 1(2H)-PyriMidineacetic acid, 4-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-2-oxo-
• CAS NO: 441780-11-6
• Molecular Formula: C₁₆H₂₃N₃O₇
• Molecular Weight: 369.36972
• Mol File: 441780-11-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1(2H)-PyriMidineacetic acid, 4-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-2-oxo-(CAS DataBase Reference)
• NIST Chemistry Reference: 1(2H)-PyriMidineacetic acid, 4-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-2-oxo-(441780-11-6)
• EPA Substance Registry System: 1(2H)-PyriMidineacetic acid, 4-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-2-oxo-(441780-11-6)

Safety Data

• Hazardous Substances Data: 441780-11-6(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule of the compound.

Explanation

The compound is derived from pyrimidineacetic acid, which is a type of organic compound containing a pyrimidine ring and a carboxylic acid group.

Explanation

The compound has an amino group (-NH2) attached to the pyrimidine ring, which is a key structural feature.

Explanation

The compound has a carbonyl group (C=O) present in the form of bis[(1,1-dimethylethoxy)carbonyl] groups.

Explanation

The compound is synthesized by first reacting pyrimidineacetic acid with bis[(1,1-dimethylethoxy)carbonyl]amine, and then oxidizing the resulting product to form the final compound.

Explanation

Due to its unique structure and functional groups, the compound may have biological activities and could be used as a building block in the synthesis of various drugs and bioactive molecules.

Explanation

While the specific biological activities of this compound are not provided, its structure suggests that it may have potential applications in the pharmaceutical industry, possibly as a drug or a precursor to other bioactive molecules.

Explanation

The compound's structure is characterized by the presence of a pyrimidine ring, an amino group, a carbonyl group, and two bis[(1,1-dimethylethoxy)carbonyl] groups, which contribute to its potential pharmaceutical applications.

Derivative of Pyrimidineacetic Acid

Yes

Contains Amino Group

Yes

Contains Carbonyl Group

Yes

Synthesis Method

Reaction of pyrimidineacetic acid with bis[(1,1-dimethylethoxy)carbonyl]amine followed by oxidation

Potential Pharmaceutical Applications

Yes

Biological Activities

Unknown (potential)

Structural Features

Pyrimidine ring, amino group, carbonyl group, and bis[(1,1-dimethylethoxy)carbonyl] groups

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1108637-30-4 methyl 2-{4-[bis(tert-butoxycarbonyl)amino]-2-oxopyrimidin-1(2H)-yl}acetate 
• 1108637-27-9 C₁₉H₂₉N₃O₇ 
• 1108637-28-0 bis-Boc-cytosine 
• 1028076-99-4 ethyl [N⁴,N⁴-bis(tert-butoxycarbonyl)cytosin-1-yl]acetate 

Downstream Products

• 1028077-19-1 benzyl N-[2-((fluorenylmethoxycarbonyl)amino)ethyl]-N-[(N⁴,N⁴-bis(tert-butoxycarbonyl)cytosin-1-yl)acetyl]glycinate 

Relevant articles and documents

Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides

Nucleopeptides are promising nucleic acid mimetics in which the peptide backbone bears nucleobases. They can recognize DNA and RNA targets modulating their biological functions. To date, the lack of an effective strategy for the synthesis of nucleopeptide

Peptide nucleic acid monomers: A convenient and efficient synthetic approach to Fmoc/Boc monomers

A convenient and cost-effective method for the synthesis of Fmoc/Boc-protected peptide nucleic acid monomers is described. The Fmoc/Boc strategy was developed in order to eliminate the solubility issues during peptide nucleic acid solid-phase synthesis, in particular that of the cytosine monomer, that occurred when using the commercialized Bhoc chemistry approach.

A convenient route to N-[2-(Fmoc)aminoethyl]glycine esters and PNA oligomerization using a bis-N-Boc nucleobase protecting group strategy

(Chemical Equation Presented) A simple and practical synthesis of the benzyl, allyl, and 4-nitrobenzyl esters of N-[2-(Fmoc)aminoethyl]glycine is described starting from the known N-(2-aminoethyl)glycine. These esters are stored as stable hydrochloride salts and were used in the synthesis of peptide nucleic acid monomers possessing bis-N-Boc-protected nucleobase moieties on the exocyclic amino groups of ethyl cytosin-1-ylacetate, ethyl adenin-9-ylacetate and ethyl (O6-benzylguanin-9-yl)acetate. Upon ester hydrolysis, the corresponding nucleobase acetic acids were coupled to N-[2-(Fmoc)aminoethyl] glycine benzyl ester or to N-[2-(Fmoc)aminoethyl]glycine allyl ester in order to retain the O6 benzyl ether protecting group of guanine. The Fmoc/bis-N-Boc-protected monomers were successfully used in the Fmoc-mediated solid-phase peptide synthesis of mixed sequence 10-mer PNA oligomers and are shown to be a viable alternative to the currently most widely used Fmoc/Bhoc-protected peptide nucleic acid monomers.